Clinical Trials

  • A person smiles and holds a spoon. A white patch is on their right upper arm.
    Image attribution tooltip
    Courtesy of Dexcom
    Image attribution tooltip

    NEJM study supports CGM use for people with diabetes who don’t take insulin

    The results come as Dexcom is awaiting a decision from the Centers for Medicare and Medicaid Services to expand Medicare coverage of the devices for people with Type 2 diabetes.

    By • Oct. 15, 2026
  • an interior shot of johnson and Johnson corporate lobby featuring signage
    Image attribution tooltip
    Permission granted by Johnson & Johnson
    Image attribution tooltip

    J&J sells Laminar LAA closure assets it bought 3 years ago

    The decision is part of J&J’s strategy to prioritize resources for the greatest impact and positions Laminar for success under dedicated ownership, a spokesperson said.

    By • Sept. 16, 2026
  • A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Maryland. Explore the Trendline➔
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip
    Trendline

    Top 5 stories from MedTech Dive

    From the effects of layoffs at the Food and Drug Administration and President Donald Trump’s tariff policies to the top medtech trends of 2026, here is a collection of top stories from MedTech Dive.

    By MedTech Dive staff
  • Scientist evaluating a scan
    Image attribution tooltip

    Adobe Stock

    Image attribution tooltip
    Sponsored by IQVIA MedTech

    Human factors isn’t a checkbox: What FDA’s eSTAR requirements mean for MedTech submissions

    FDA’s eSTAR framework raises the bar for documenting human factors and use-related risk.

    By Di Lu, Associate Director, Regulatory Affairs | Human Factors and Usability Engineering at IQVIA MedTech • Sept. 14, 2026
  • A picture of the exterior of a Labcorp building.
    Image attribution tooltip
    Courtesy of Labcorp
    Image attribution tooltip

    Labcorp acquires MLM Medical Labs in global expansion

    Buying MLM gives Labcorp a wholly owned laboratory network that spans North America, Europe, Asia and Africa.

    By • Sept. 9, 2026
  • Abbott Laboratories
    Image attribution tooltip
    Courtesy of Abbott
    Image attribution tooltip

    Abbott ablation device effective at 1 year in complex cases

    Abbott said it will use the study results to secure FDA approval for the TactiFlex Duo catheter that offers both PFA and RF energy for tailoring treatment of atrial fibrillation.

    By • Sept. 2, 2026
  • An image of white mesh material.
    Image attribution tooltip
    Courtesy of BD
    Image attribution tooltip

    BD fully enrolls trial of resorbable mesh for hernia prevention

    BD called completing enrollment in the study “a significant milestone in its advanced tissue regeneration strategy and expansion efforts.”

    By • Aug. 13, 2026
  • The handheld controllers of MMI's Symani robot are demonstrated.
    Image attribution tooltip
    Courtesy of MMI
    Image attribution tooltip

    MMI to expand study of robotic microsurgery for Alzheimer’s

    The FDA is allowing MMI to enroll more patients in a feasibility trial studying use of the Symani robot for microsurgery to restore drainage paths in the lymph nodes of Alzheimer's patients.

    By • July 31, 2026
  • An image of Abbott's TriClip device to repair the tricuspid valve.
    Image attribution tooltip
    Permission granted by Abbott
    Image attribution tooltip

    Abbott starts TriClip study amid rising competition for heart valve repair

    Facing competition from Edwards, Abbott is studying TriClip’s real-world safety and performance in about 1,000 patients.

    By • July 29, 2026
  • An image of Edwards Lifesciences' campus in Irvine, California.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    Edwards posts strong TAVR sales ahead of potential Medicare coverage expansion

    An upcoming Medicare coverage decision for transcatheter aortic valve replacement devices and study readout for patients with moderate disease are expected to help the company maintain its momentum.

    By • July 24, 2026
  • An illustration of pain in the colon.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Freenome colorectal cancer test data improve on earlier results

    The new study results could make Abbott, which has an agreement with Freenome to market the blood-based test, the dominant player in colorectal cancer screening, Evercore ISI analysts said.

    By • July 13, 2026
  • Illustration of a blood clot blocking red blood cells within an artery or a vein.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Penumbra starts trial of clot removal device in stroke subgroup

    Penumbra, which is set to become part of Boston Scientific this year, is running the trial to inform the treatment of a type of medium-vessel blockage.

    By • July 8, 2026
  • A ShockWave sonic catheter
    Image attribution tooltip
    Permission granted by ShockWave
    Image attribution tooltip

    J&J starts pivotal trials of Shockwave IVL device in carotid arteries

    J&J is working to expand use of Shockwave’s technology as competition in intravascular lithotripsy builds from companies like Boston Scientific and Stryker.

    By • June 29, 2026
  • FDA magnifying glass
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    HHS, responding to China’s rise, moves to fast-track early drug research

    A series of newly planned reforms are designed to entice companies to start early trials in the U.S. rather than overseas.

    By Jonathan Gardner • June 24, 2026
  • A person walks in a forest with a square device taped to their thigh.
    Image attribution tooltip
    Courtesy of Tandem Diabetes Care
    Image attribution tooltip

    3 takeaways from ADA

    Tandem Diabetes Care, Insulet and Dexcom all presented data over the weekend at the American Diabetes Association’s Scientific Sessions.

    By • June 8, 2026
  • A Grail employee in white coat and blue gloves works with a blood sample.
    Image attribution tooltip
    Courtesy of Grail
    Image attribution tooltip

    At ASCO, Grail points to positive signals in MCED data

    Grail executives were upbeat on study results for the Galleri multi-cancer early detection test, while ASCO said more evidence is needed before it is incorporated into screening guidelines.

    By • June 2, 2026
  • A picture of Siemens Healthineers' headquarters building in Erlangen, Germany.
    Image attribution tooltip
    Courtesy of Siemens Healthineers
    Image attribution tooltip

    Siemens Healthineers, AiM team up; Procept completes study enrollment

    Siemens Healthineers’ MRI scanners would guide robotic neurosurgeries performed with AiM’s platform. Elsewhere, Procept finished enrollment in a study of its aquablation treatment in prostate cancer.

    By • May 28, 2026
  • A coil-shaped device is shown moving through a tube with branching structures around it.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic data back renal denervation in the long term

    Analyses presented at EuroPCR assessed Medtronic’s Symplicity blood pressure procedure in patient groups with severe hypertension and who had prior cardiovascular events.

    By • May 20, 2026
  • A catheter device is shown against a white background.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific posts positive data for coronary IVL catheter

    With the study results, Boston Scientific plans a regulatory submission for the intravascular lithotripsy treatment for patients with severely calcified coronary artery disease.

    By • May 19, 2026
  • An image of a GI robot.
    Image attribution tooltip
    Permission granted by Neptune Medical
    Image attribution tooltip

    Neptune Medical’s GI robot succeeds in colonoscopy study

    The first-in-human study showed no adverse events and a 100% rate of cecal intubation, where the endoscope is guided to the beginning of the large intestine.

    By • May 6, 2026
  • A wall bearing the Johnson & Johnson logo is seen outside of an office building.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    J&J’s Ottava robot meets goals in gastric bypass study

    The findings for patients 30 days after surgery were included in a package of data supporting J&J’s submission to the FDA for de novo authorization.

    By • May 6, 2026
  • A person runs in a soccer field wearing two white devices taped to their upper arms.
    Image attribution tooltip
    Courtesy of Insulet
    Image attribution tooltip

    Insulet starts study of closed loop insulin delivery system

    Indicated for people with Type 2 diabetes, the system would be Insulet’s first fully automated device for insulin delivery.

    By • May 4, 2026
  • A picture of a blue pulsed field ablation catheter against a gray background.
    Image attribution tooltip
    Courtesy of Johnson & Johnson MedTech
    Image attribution tooltip

    J&J starts head-to-head PFA trial against Boston Scientific device

    The study will compare outcomes on J&J’s Varipulse Pro platform and Boston Scientific’s rival Farapulse PFA system.

    By • April 28, 2026
  • Boston Scientific's Farawave pulsed field ablation catheter is shown against a white background.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    4 studies to know from HRS 2026

    Boston Scientific, Abbott and Medtronic shared new cardiac device data at the annual Heart Rhythm Society meeting, where market share shifts in pulsed field ablation were on analysts’ minds.

    By • April 27, 2026
  • A modern two-story commercial office building with a mix of gray and wood paneling on the exterior. Large glass windows dominate both floors, and the front entrance features the "Medtronic" logo above double glass doors. The surrounding area includes a few small shrubs and empty parking spaces in front.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Medtronic confirms paclitaxel balloon’s efficacy in post-approval trial

    The end-stage kidney disease device performed as well in the study as in a pivotal trial that supported FDA approval.

    By • April 16, 2026
  • FDA
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    VDyne secures FDA nod to start pivotal trial for tricuspid valve

    With approval to study the transcatheter replacement device in patients with severe tricuspid regurgitation, VDyne is advancing a treatment to compete with Edwards Lifesciences’ Evoque system.

    By • April 6, 2026